165 related articles for article (PubMed ID: 1336473)
1. Anti-hepatitis C virus immunoglobulin M antibody in patients with chronic hepatitis type C.
Kikuchi T; Onji M; Michitaka K; Ohta Y
Hepatogastroenterology; 1992 Dec; 39(6):525-8. PubMed ID: 1336473
[TBL] [Abstract][Full Text] [Related]
2. The significance of immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C.
Yuki N; Hayashi N; Ohkawa K; Hagiwara H; Oshita M; Katayama K; Sasaki Y; Kasahara A; Fusamoto H; Kamada T
Hepatology; 1995 Aug; 22(2):402-6. PubMed ID: 7543432
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
Quiroga JA; van Binsbergen J; Wang CY; Pardo M; Navas S; Trines C; Herrero M; Carreño V
Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
[TBL] [Abstract][Full Text] [Related]
5. Significance of serum immunoglobulin M to hepatitis C virus core in patients with chronic hepatitis C.
Tran A; Yang G; Dreyfus G; Rouquié P; Durant J; Rampal A; Rampal P; Benzaken S
Am J Gastroenterol; 1997 Oct; 92(10):1835-8. PubMed ID: 9382047
[TBL] [Abstract][Full Text] [Related]
6. Anti-hepatitis C antibodies in patients with chronic non-A, non-B hepatitis: relation to disease progression and effect of interferon alpha.
Yoshioka K; Kakumu S; Hayashi H; Shinagawa T; Wakita T; Ishikawa T; Itoh Y; Takayanagi M
Am J Gastroenterol; 1991 Oct; 86(10):1495-9. PubMed ID: 1928044
[TBL] [Abstract][Full Text] [Related]
7. Detection of anti-HCV IgM antibodies in patients with chronic hepatitis C treated with interferon.
Picciotto A; Icardi G; Bardellini E; Borro P; Borzone S; Pireddu M; Sinelli N; Pezzano D; Orione L; Di Giacomo C
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):623-5. PubMed ID: 8590156
[TBL] [Abstract][Full Text] [Related]
8. Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status.
Ohnishi K; Nomura F; Nakano M
Am J Gastroenterol; 1991 Aug; 86(8):1041-9. PubMed ID: 1650129
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of anti-hepatitis C virus (HCV) IgM and HCV-RNA detection in serum samples of patients with HCV infection].
Lei Z; Lu H; Han F; Shi H; Lu J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):121-3. PubMed ID: 15619814
[TBL] [Abstract][Full Text] [Related]
10. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.
Baumert TF; Wellnitz S; Aono S; Satoi J; Herion D; Tilman Gerlach J; Pape GR; Lau JY; Hoofnagle JH; Blum HE; Liang TJ
Hepatology; 2000 Sep; 32(3):610-7. PubMed ID: 10960457
[TBL] [Abstract][Full Text] [Related]
11. [Anti-HCV test in patients with chronic non-A, non-B hepatitis].
Havelka J; Zala G; Joller-Jemelka HJ; Altorfer J; Meier B; Schmid M; Bühler H
Schweiz Med Wochenschr; 1992 Feb; 122(6):198-200. PubMed ID: 1311126
[TBL] [Abstract][Full Text] [Related]
12. [Sequential monitoring of various HCV-related markers in chronic hepatitis C with interferon treatment].
Nagayama R; Shoji S; Miyake K
Nihon Rinsho; 1994 Jul; 52(7):1789-93. PubMed ID: 7521419
[TBL] [Abstract][Full Text] [Related]
13. Detection of hepatitis C virus antibody by first and second generation assays and polymerase chain reaction in patients with autoimmune chronic active hepatitis types I, II, and III.
Mitchel LS; Jeffers LJ; Reddy KR; Cheinquer H; Coelho-Little E; Moreda R; Parker T; Silva M; Li XM; de Medina M
Am J Gastroenterol; 1993 Jul; 88(7):1027-34. PubMed ID: 7686329
[TBL] [Abstract][Full Text] [Related]
14. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
Sakashita H
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
[TBL] [Abstract][Full Text] [Related]
16. Clinical importance of assessment of anti-HCV IgM antibodies in chronic hepatitis C.
Stránský J; Honzáková E; Vandasová J; Horejsová M; Kyncl J; Nĕmecek V; Horák J
Acta Virol; 1996 Apr; 40(2):61-5. PubMed ID: 8886113
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of antibodies to hepatitis C virus among Saudi patients with chronic liver diseases.
Ayoola EA; al-Mofleh IA; al-Faleh FZ; al-Rashed R; Arif MA; Ramia S; Mayet I
Hepatogastroenterology; 1992 Aug; 39(4):337-9. PubMed ID: 1385286
[TBL] [Abstract][Full Text] [Related]
18. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
[TBL] [Abstract][Full Text] [Related]
19. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.
Nagayama R; Miyake K; Tsuda F; Okamoto H
J Med Virol; 1994 Mar; 42(3):311-7. PubMed ID: 7516423
[TBL] [Abstract][Full Text] [Related]
20. [The diagnostic significance of anti-HCV IgM in chronic hepatitis C viral infection].
Wu H; Wang J; Lin X
Zhonghua Nei Ke Za Zhi; 1995 Jan; 34(1):42-5. PubMed ID: 7541329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
